Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models

Ilaria Marrocco, Donatella Romaniello, Itay Vaknin, Diana Drago-Garcia, Roni Oren, Mary Luz Uribe, Nishanth Belugali Nataraj, Soma Ghosh, Raya Eilam, Tomer Meir Salame, Moshit Lindzen, Yosef Yarden

Research output: Contribution to journalArticlepeer-review

13 Scopus citations

Fingerprint

Dive into the research topics of 'Upfront admixing antibodies and EGFR inhibitors preempts sequential treatments in lung cancer models'. Together they form a unique fingerprint.

Medicine & Life Sciences